CTRI/2024/02/062723
Not yet recruiting
Phase 4
Dedicated Branch Stent vs Conventional Stent in Bifurcation Coronary stenosis -A medium term followup
ESIC Super Speciality Hospital0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ESIC Super Speciality Hospital
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.The patientmustbegreaterthan euqal 18 years of age.2\.True coronary bifurcation greaterthan equal to 50 percentage diameter stenosis in both the main and side branches, belonging to the Medina classes 1,1,1 or 1,0,1 or 0,1,1\.3\.Patients with de novo bifurcation lesions in native coronary arteries with reference diameter ranging from 2\.5 mm to 3\.5 mm in the side branch and 2\.5 mm to 4\.0 mm in main branch4\.Patient must agree not to participate in any other clinical trial for a period of two years following the index procedure.
- •5\.The patient is willing to comply with protocol specified follow\-up evaluations.6\.Patient or his or her legally authorized representative if applicable agrees to provide written informed consent as approved by respective Ethics Committee and applicable regulatory authorities.
Exclusion Criteria
- •1\.Patients with hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, drug such as Sirolimus Rapamycin or similar drugs or any analogue or derivative, cobalt, chromium, nickel, molybdenum, tungsten or any contrast media.2\.Patients in whom anti\-platelet and or anticoagulant therapy are contraindicated. 3\.Angiographic evidence of thrombus.4\.Direct stenting of the left main bifurcation 5\.Impaired runoff in the treatment vessel with diffuse distal disease.6\.A significant greaterthan 50 percentage stenosis proximal to distal to the target lesion.
- •7\.Ejection fraction lessthan 30 percentage 8\.Patient requiring anticipated rotational atherectomy as per the Investigators judgement.
- •9\.Highly calcified lesions in which full stent dilatation may not be possible.10\.Patients with totally occluded vessel.11\.Target lesion has excessive tortuosity unsuitable for stent delivery and deployment. 12\.Patients judged to have a lesion that prevents complete inflation of an angioplasty balloon. 13\.Patient has undergone heart transplant or any other organ transplant or planned to undergo any organ transplant. 14\.Pregnant or nursing patients or those who plan pregnancy during study period 15\.Any condition, which in the Investigators opinion would preclude safe participation of patient in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness and safety of branched type stent graft for aortic arch diseaseAortic arch diseaseJPRN-UMIN000033298Suita Tokushukai Hospital20
Completed
Not Applicable
Effectiveness and safety study of branched stent-graft for aortic arch diseaseaortic arch diseaseJPRN-UMIN000019662Osaka University20
Completed
Not Applicable
Bioabsorbable stent implantation versus endarterectomy for atherosclerotic lesions in the common femoral arteryAtherosclerosis. Peripheral arterial occlusive disease. Fontaine stages IIb-IVCirculatory SystemArteriosclerosisISRCTN81656089Paracelsus Medical University (PMU) (Paracelsus Medizinische Privatuniversität) (Austria)214
Completed
Not Applicable
reteric stent in kidney transplantatioTopic: Renal disordersSubtopic: Renal disordersDisease: All Renal disordersUrological and Genital DiseasesISRCTN89369862Central Manchester & Manchester Childrens University Hospital NHS Trust300
Completed
Not Applicable
Evaluation of the stent types for bilateral stent-in-stent placement for malignant hilar biliary obstructioThe case of the malignant hilar biliary obstruction with bilateral stent-in-stent metallic stent placemenJPRN-UMIN000047870Gifu Municipal Hospital78